Literature DB >> 9133680

Iodine metabolism and thyroid physiology: current concepts.

R R Cavalieri1.   

Abstract

Iodine plays a central role in thyroid physiology, being both a major constituent of thyroid hormones (THS) and a regulator of thyroid gland function. This review concerns those aspects of thyroid physiology in which significant advances have been made in recent years. We have known for decades that the thyroid gland concentrates iodine (I-) against an electrochemical gradient by a carrier-mediated mechanism driven by ATP. A similar I- uptake mechanism is found in other organs, including salivary glands, stomach, choroid plexus, and mammary glands, but only in the thyroid does TSH regulate the process. This past year saw a major advance with the cloning of the thyroid I- transporter. This development opens the way to an elucidation of the regulation of I- transport in the normal gland and in thyroid neoplasms that lack this property ("cold" nodules). All of the subsequent steps in TH biosynthesis, from oxidation and organification of iodide to the secretion of T4 and T3 into the circulation, are stimulated by TSH and inhibited by excess iodine. Recently, some of the regulatory mechanisms have been clarified. The function of the major TH-binding proteins in plasma is to maintain an equilibrium between extracellular and cellular hormone pools. Transthyretin, the principal T4-binding protein in cerebrospinal fluid, may play a similar role in the central nervous system. Although it generally is agreed that cellular uptake of TH is a function of the unbound (free) form of the hormone, there is evidence that certain TH-binding plasma proteins (i.e., apolipoproteins) may serve specific transport functions. The intracellular concentration of T3, the active TH, is determined by the rates of cellular uptake of T4 and T3, the rates of metabolic transformation, including conversion of T4 to T3, and the rate of T3 efflux. The latter has been assumed to be a passive process. However, recent studies by our group in San Francisco have shown that T3 is transported out of cells by a specific, saturable, verapamil-inhibitable mechanism. This T3 efflux system is widespread among cells from many tissues, and, at least in liver, modulates intracellular and nuclear concentration of the hormone and thereby influences TH action.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9133680     DOI: 10.1089/thy.1997.7.177

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  31 in total

1.  Assessment of the Effect of Two Distinct Restricted Iodine Diet Durations on Urinary Iodine Levels (Collected over 24 h or as a Single-Spot Urinary Sample) and Na(+)/I(-) Symporter Expression.

Authors:  Rosália P Padovani; Rui M B Maciel; Teresa S Kasamatsu; Beatriz C G Freitas; Marilia M S Marone; Cleber P Camacho; Rosa Paula M Biscolla
Journal:  Eur Thyroid J       Date:  2015-06-11

2.  Fixed sporotrichosis as a cause of a chronic ulcer on the knee.

Authors:  Rodrigo Roldán-Marín; José Contreras-Ruiz; Roberto Arenas; Elsa Vazquez-del-Mercado; Sonia Toussaint-Caire; María Elisa Vega-Memije
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

Review 3.  Thyroid hormone therapy in differentiated thyroid cancer.

Authors:  Giorgio Grani; Valeria Ramundo; Antonella Verrienti; Marialuisa Sponziello; Cosimo Durante
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

4.  (131)I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study.

Authors:  Kuan-Yin Ko; Chia-Hung Kao; Cheng-Li Lin; Wen-Sheng Huang; Ruoh-Fang Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-22       Impact factor: 9.236

5.  Safety profile after prolonged C3 inhibition.

Authors:  Edimara S Reis; Nadja Berger; Xin Wang; Sophia Koutsogiannaki; Robert K Doot; Justin T Gumas; Periklis G Foukas; Ranillo R G Resuello; Joel V Tuplano; David Kukis; Alice F Tarantal; Anthony J Young; Tetsuhiro Kajikawa; Athena M Soulika; Dimitrios C Mastellos; Despina Yancopoulou; Ali-Reza Biglarnia; Markus Huber-Lang; George Hajishengallis; Bo Nilsson; John D Lambris
Journal:  Clin Immunol       Date:  2018-10-10       Impact factor: 3.969

6.  Active Site Binding Is Not Sufficient for Reductive Deiodination by Iodotyrosine Deiodinase.

Authors:  Nattha Ingavat; Jennifer M Kavran; Zuodong Sun; Steven E Rokita
Journal:  Biochemistry       Date:  2017-02-16       Impact factor: 3.162

Review 7.  The changing epidemiology of iodine deficiency.

Authors:  Mu Li; Creswell J Eastman
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

8.  Do thyroxine and thyroid-stimulating hormone levels reflect urinary iodine concentrations?

Authors:  Offie P Soldin; Rochelle E Tractenberg; John C Pezzullo
Journal:  Ther Drug Monit       Date:  2005-04       Impact factor: 3.681

9.  Management of amiodarone-related thyroid problems.

Authors:  Shashithej K Narayana; David R Woods; Christopher J Boos
Journal:  Ther Adv Endocrinol Metab       Date:  2011-06       Impact factor: 3.565

10.  Significance of Salivary Gland Radioiodine Retention on Post-ablation (131)I Scintigraphy as a Predictor of Salivary Gland Dysfunction in Patients with Differentiated Thyroid Carcinoma.

Authors:  Kyung Sook Jo; Young-Sil An; Su Jin Lee; Euy-Young Soh; Jeonghun Lee; Yoon-Sok Chung; Dae Jung Kim; Seok-Ho Yoon; Dong Hyun Lee; Joon-Kee Yoon
Journal:  Nucl Med Mol Imaging       Date:  2014-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.